The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent ...

April 3 (Reuters) - British pharmaceutical giant GlaxoSmithKline (GSK.L), opens new tab and rival Pfizer (PFE.N), opens ... 16 PM UTC · Updated ago category No Fed 'put' when it's unclear which ...

April 1 (Reuters) - The European Commission approved Pfizer's (PFE.N), opens new tab respiratory syncytial virus vaccine for the prevention of lower respiratory tract disease caused by RSV in ...

It’s not HBO, it’s Max — but the new standalone logo for Warner Bros. Discovery‘s streamer now certainly looks like HBO’s at a glance. The Max streaming service has quietly launched a ...

We are under an ABC-7 First Alert in preparation for a gusty and dusty Tuesday in the Borderland. Today and tomorrow is looking nice! Today will have low-end winds and warm weather and tomorrow ...

U.S. President Donald Trump signs an executive order about tariffs increase in the Oval Office of the White House in Washington, D.C. Kevin Lamarque/Reuters President Donald Trump has announced ...

From 2021 through 2024, Pfizer paid more than $12.8 billion in U.S. income taxes, as publicly reported in the company’s financials and securities filings, the spokesperson added.

Senator Ron Wyden (D-Ore.), a senior member of the Senate Finance Committee, accused Pfizer (PFE) of carrying out what he described as potentially the biggest tax-dodging scheme in pharmaceutical ...

Federal investigators are investigating claims suggesting Pfizer delayed announcing test results of its Covid vaccine until after the 2020 presidential election, the Wall Street Journal reported ...

The tip comes from GSK employees who worked with Philip Dormitzer, M.D., Ph.D., a Pfizer-turned-GSK scientist who headed up vaccine R&D and infectious disease research at GSK for three years ...